EFFECTS OF CHANGES IN CONDITIONING REGIMEN AND SUPPORTIVE CARE ON OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT)

被引：0
|
作者：
Abello, V [1 ]
Rosales, C. [1 ]
Pedraza, E. [1 ]
Linares, A. [1 ]
Esguerra, H. [1 ]
Rosales, M. [1 ]
Figueroa, J. [1 ]
机构：
[1] Clin Marly, Bogota, Colombia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
200
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [21] A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)
    Martin-Antonio, Beatriz
    Suarez-LLedo, Maria
    Arroyes, Montserrat
    Fernandez-Aviles, Francesc
    Martinez, Carmen
    Rovira, Montserrat
    Espigado, Ildefonso
    Gallardo, David
    Bosch, Anna
    Buno, Ismael
    Martinez-Laperche, Carolina
    Jimenez-Velasco, Antonio
    De La Camara, Rafael
    Brunet, Salut
    Nieto, Jose B.
    Urbano-Ispizua, Alvaro
    BLOOD, 2012, 120 (21)
  • [22] Allogeneic stem cell transplantation (allo-SCT) in patients with secondary acute myelogenous leukemia (AML) or high risk myelodysplastic syndromes (MDS)
    El-Cheikh, J
    Faucher, C
    Mohty, M
    Stoppa, AM
    Lafage-Pochitaloff, M
    Coso, D
    Moziconacci, MJ
    Bouabdallah, R
    Gastaut, JA
    Blaise, D
    Vey, N
    BLOOD, 2005, 106 (11) : 440B - 440B
  • [23] Comparable outcomes for Fludarabine/TBI versus Fludarabine/Treosulfan conditioning prior to allogeneic stem cell transplantation (Allo-SCT) in AML and MDS patients
    Berning, P.
    Kolloch, L.
    Reicherts, C.
    Call, S.
    Marx, J.
    Floeth, M. P.
    Esseling, E.
    Schliemann, C.
    Lenz, G.
    Stelljes, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 140 - 140
  • [24] Sequential Chemotherapy Followed by Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of EBMT
    Ringden, Olle
    Labopin, Myriam
    Kolb, Hans Jochem
    Michallet, Mauricette
    Kroeger, Nicolaus
    Ganser, Arnold
    Bunjes, Donald
    Hallek, Michael
    Kanz, Lothar
    Schwerdtfeger, Rainer
    Holler, Ernst
    Arnold, Renate
    Huynh, Anne
    Nagler, Arnon
    Schmid, Christoph
    Mohty, Mohamad
    BLOOD, 2012, 120 (21)
  • [25] Total body irradiation (TBI)-based versus chemotherapy-based myeloablative conditioning regimen before allogeneic stem cell transplantation (allo-sct) for acute myeloid leukemia (AML). A single centre experience
    Carella, A. M.
    Angarano, R.
    Merla, E.
    Greco, M. M.
    Savino, L.
    Troiano, M.
    Parisi, S.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S591 - S591
  • [26] Allogeneic Stem Cell Transplantation (Allo-SCT) in Adults with Acute Myelogenous Leukemia (AML). Final Analysis of JALSG AML97 Study
    Sakamaki, Hisashi
    Miyawaki, Shuichi
    Ohtake, Shigeki
    Emi, Nobuhiko
    Yagasaki, Fumiharu
    Mitani, Kinuko
    Matsuda, Shin
    Kishimoto, Yuuji
    Miyazaki, Yasushi
    Asou, Norio
    Takahashi, Masatomo
    Ogawa, Yoshiaki
    Honda, Sumihisa
    Ohno, Ryuzo
    BLOOD, 2008, 112 (11) : 135 - 136
  • [27] The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen
    Ayas, Mouhab
    Al-Seraihi, Amal
    Al-Mahr, Mohamad
    Al-Jefri, Abdullah
    Belgaumi, Assim
    Elhassan, Ibrahim
    El-Solh, Hassan
    PEDIATRIC BLOOD & CANCER, 2006, 47 (07) : 926 - 930
  • [28] Graft-Versus-Leukemia (GVL) Effect After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Treatment for Acute Myeloid Leukemia (AML): a Survey From the Acute Leukemia Working Party of the EBMT
    Baron, Frederic
    Labopin, Myriam
    Mohty, Mohamad
    Basara, Nadezda
    Niederwieser, Dietger
    Milpied, Noel-Jean
    Cornelissen, J. J.
    Malm, Claes
    Sengeloev, Henrik
    Blaise, Didier
    Janssen, Jeroen J. W. M.
    Petersen, Eefke
    Socie, Gerard
    Rocha, Vanderson
    BLOOD, 2009, 114 (22) : 1284 - 1285
  • [29] UNRELATED DONOR (UD) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA (AML): REPORT OF 381 PATIENTS FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT
    Brissot, E.
    Labopin, M.
    Stelljes, M.
    Ehninger, G.
    Schwerdtfeger, R.
    Zander, A. R.
    Mielke, S.
    Ganser, A.
    Finke, J.
    Schufer-Eckart, K.
    Bunjes, D.
    Kroeger, N.
    Schmid, C.
    Bethge, W. A.
    Kolb, H. J.
    Blau, I. W.
    Vitek, A.
    Bochtler, T.
    Meyer, R. G.
    Holler, E.
    Esteve, J.
    Nagler, A.
    Mohty, M.
    HAEMATOLOGICA, 2015, 100 : 13 - 14
  • [30] Allogeneic stem cell transplantation (allo-SCT) with sequential conditioning in patients with relapsed/refractory acute lymphoblastic leukemia: A report from EBMT acute leukemia working party
    Bazarbachi, Abdul Hamid
    Al Hamed, Rama
    Myriam, Labopin
    Afanasyev, Boris
    Hamladji, Rose-Marie
    Dietrich, Beelen
    Arnold, Ganser
    Christof, Scheid
    Wu Depei
    Donald, Bunjes
    Stepensky, Polina
    Tischer, Johanna
    Kroeger, Nicolaus
    Peric, Zina
    Giebel, Sebastian
    Nagler, Arnon
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2019, 54 : 152 - 152
12345